Navigation Links
Revolutionary nanotechnology illuminates brain cells at work

Until now it has been impossible to accurately measure the levels of important chemicals in living brain cells in real time and at the level of a single cell. Scientists at the Carnegie Institution's Department of Plant Biology and Stanford University are the first to overcome this obstacle by successfully applying genetic nanotechnology using molecular sensors to view changes in brain chemical levels. The sensors alter their 3-dimensional form upon binding with the chemical, which is then visible via a process known as fluorescence resonance energy transfer, or FRET. In a new study, the nanosensors were introduced into nerve cells to measure the release of the neurotransmitter glutamate--the major brain chemical that increases nerve-cell activity in mammalian brains. It is involved in everything from learning and memory to mood and perception. Too much glutamate is believed to contribute to conditions such as Alzheimer's and Parkinson's disease. The research is published in the May 30-June 3 on-line early edition of the Proceedings of the National Academy of Sciences.

"The fluorescent imaging technique allows us to see living cells do their jobs live and in color," explained Sakiko Okumoto, lead author of the study at Carnegie. "Understanding when and how glutamate is produced, secreted, reabsorbed, and metabolized in individual brain cells, in real time, will help researchers better understand disease processes and construct new drugs."

"FRET is like two musical tuning forks, which have the same tone," Okumoto continued. "If you excite one, it gives a characteristic tone. If you bring the second fork close to the first one, it will also start to give you a tone even though they do not touch. This is resonance energy transfer."

FRET is used to track the form of proteins that specifically bind metabolites such as sugars and amino acids. A protein of interest is genetically fused with two differently colored tags made from variants of the jelly
'"/>

Source:Carnegie Institution


Page: 1 2 3

Related biology news :

1. Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses
2. New nanotechnology able to examine single molecules, aiding in determining gene expression
3. Iowa State scientists demonstrate first use of nanotechnology to enter plant cells
4. Drawing with DNA: Bioart illuminates genomics
5. New fruit fly protein illuminates circadian response to light
6. Study illuminates how the plague bacteria causes disease
7. Genome archaeology illuminates the genetic engineering debate
8. Controversial drug shown to act on brain protein to cut alcohol use
9. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
10. Mouse brain tumors mimic those in human genetic disorder
11. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows

Post Your Comments:
(Date:11/4/2009)... Long Beach and Riverside are responsible for a si...ma, and the true impact of air pollution and ship ...mated, according to researchers at the University ...h appears in an online edition of the American Jo...nt of all childhood asthma cases in Long Beach and...
(Date:11/4/2009)... the DNA codes, or genomes, of the famed fugu (or ...ome 10K Project, an international effort to build ...0 species of animals for conducting comparative st...d. , Participating in The Genome 10K project, de...ssue of the Journal of Heredity , are 70 leading ...
(Date:11/4/2009)...irstCall/ -- Quest Diagnostics Incorporated (NYSE:...c testing, information and services, announced tha...income from continuing operations rose to $192 mil...n, or $0.81 per diluted share, for the third quart...duced by a $0.03 per share charge associated with ...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 1Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 2Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 3New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 1New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 2New Surgical Device Revolutionizes Face Lifts Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time Less Pain and Few 53461 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7
... where and how some plant seeds store iron, a valu...he iron content of plants. Their research helps ad... malnutrition in humans. , The team found that iro...he seed of Arabidopsis, a model plant used in rese..., a plant cell,s central storage site. The researc...
...oxycycline effectively treats a type of lymphoma a... study in the October 4 issue of the Journal of ...lymphoma of the MALT-type (OAL) is a kind of cance...ten fatal, but its symptoms can compromise a patie...an association between OAL and infection with the ...
...nia Bioinformatics Institute and Duke University M...ppears to play an important role in the developmen...assicicola, a destructive fungal pathogen that cau... crops worldwide, results in considerable leaf los...anola, cabbage and broccoli. Sensitivity to spore...
Other Biology News:Plant studies reveal how, where seeds store iron 2Tearing down the fungal cell wall 2Tearing down the fungal cell wall 3
(Date:11/5/2009)...v. 5 Imagenetix, Inc. (O...liam Spencer, President and CEO of Imagenetix, wil...ual LD MICRO Conference on Thursday, December 3rd,.... ,, About LD MICRO ,, LD MICRO is a by-invi...g undervalued companies in the micro-cap space. Si...
(Date:11/5/2009)...ll on Thursday, November 5, 2009 at 4:30 p.m. East...PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals,...I ) today reported unaudited financial results for... 30, 2009 and reviewed the Company,s highlights fo...onsolidated results reflect the operations of Onco...
(Date:11/5/2009)...., Nov. 5 BioSpecifics T...tical company developing first-in-class collagenas...sults for the third quarter ended September 30, 20...mber of this year, the FDA,s Arthritis Advisory Co..., the approval of XIAFLEX(TM) for the treatment of...
(Date:11/5/2009)...exas, Nov. 5 Wound Manag...that it has entered into a Letter of Intent to pur...lth Technologies, Inc. (OTC Bulletin Board: VHGI)....in cash and debt, 4,000,000 shares of WNDM and a r... the Veriscrip technology being acquired from VHGI...
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ewswire-FirstCall/ - Neptune Technologies & Bi...NTB) provides an update on business activities reg...Sales and Distribution Update, - Neptune expand... of two, additional marketing and sales execu...ckgrounds in the nutraceutical and functional food...
...(May 4, 2009): Uveitis, or inflammation within the... of visual loss roughly comparable to that caused ...ational Phase 3 program in uveitis, the LUMINATE t...e ability of LX211 (LUVENIQ, voclosporin oral caps...lammation. Additionally, in patients who are disco...
... Novavax, Inc. (Nasdaq: NVAX ) today announced ...al results in a press release to be issued after 8...Company will hold an investor conference call to d... Time on Friday, May 8, 2009. The call will be hos...er Dr. Rahul Singhvi and other members of senior m...
Other Biology Technology:Neptune Product and Distribution Update 2Neptune Product and Distribution Update 3Neptune Product and Distribution Update 4First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 2First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 3First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 4Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call 2
Bulk Enzymes/Bulk Proteins from Molecular Biology Resources
...rom balances and scales with RS232 ports and sends...f you can type the weight into the program, Balanc...mple to use parser extracts required data , Add da...llect data at timed intervals , Keyboard macros au...
Rabbit Anti-Human Prolactin Releasing Hormone Receptor (GPR10) Polyclonal Antibody, Unconjugated from IMGENEX
...ance data collection and automation that is contro...h Microsoft Excel , Pre-configured library of int...s , New balances can be added and configured by th...o one spreadsheet , Allows for multi-tasking dur...
Biology Products: